Poseida Therapeutics Inc

NASDAQ:PSTX   1:44:29 PM EDT
7.39
-0.22 (-2.89%)
Earnings Announcements

Poseida Therapeutics Reports Program Updates And Q2 Financial Results

Published: 08/12/2021 22:11 GMT
Poseida Therapeutics Inc (PSTX) - Poseida Therapeutics Reports Program Updates and Financial Results for the Second Quarter of 2021.
Poseida Therapeutics, Inc. - Qtrly Loss per Share $0.74.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.69

More details on our Analysts Page.